Inhibikase Therapeutics, Inc.

NASDAQ:IKT

Biotechnology

Healthcare
$1.30 +3.57%

+$0.06 today

Market cap
$182.35M
Beta
0.97
P/E (TTM)
-3.4
EPS (TTM)
-$0.52
52W Low $1.33High $2.26

Volume 0.50M

Average 1.03M

Price history

Inhibikase Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-15.03%

Period high

$2.52

Period low

$1.30

Latest

$1.30

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 10, 2026Nov 10, 2026
10-QNov 10, 2026Nov 10, 2026
4Oct 21, 2026Oct 21, 2026
3Oct 21, 2026Oct 21, 2026
8-KOct 20, 2026Oct 20, 2026
8-KSep 8, 2026Sep 8, 2026
8-KAug 26, 2026Aug 26, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
10-QAug 11, 2026Aug 11, 2026
S-8Aug 11, 2026Aug 11, 2026
8-KAug 11, 2026Aug 11, 2026
4Jul 31, 2026Jul 31, 2026
4Jul 31, 2026Jul 31, 2026

Competitors

Who does Inhibikase Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about IKT's filings, answered from its disclosures.

What is the latest IKT filing?

The latest filing shown is 8-K dated Nov 10, 2026.

How many recent filings does IKT have?

Intrinsic Alpha currently shows 20 recent filings for IKT.